GSK, Vir ramping up U.S. output of COVID antibody drug
Go back to GSK, Vir ramping up U.S. output of COVID antibody drug| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 41.24 +0.65 (1.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.59 | 52 Week High | $45.58 | |||
| Open | $40.66 | 52 Week Low | $37.82 | |||
| Day High | $41.26 | P/E | N/A | |||
| Day Low | $40.60 | EPS | $0.00 | |||
| Volume | 2,291,009 | |||||
| (NASDAQ: VIR) | Delayed: 8.13 +0.03 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.10 | 52 Week High | $ | |||
| Open | $8.10 | 52 Week Low | $ | |||
| Day High | $8.29 | P/E | N/A | |||
| Day Low | $8.07 | EPS | $ | |||
| Volume | 768,972 | |||||
